Neuronetics Receives 510(k) Clearance for D-Tect MT Accessory

Malvern, Pa.-based Neuronetics has received 510(k) clearance from the FDA for its D-Tect MT motor threshold mapping accessory.

The device visually reports the magnitude of finger movements during motor threshold mapping for the treatment of major depressive disorder. Motor threshold is an indicator used to determine transcranial magnetic stimulation levels for patient response.

The accessory, which is designed to recognize movement in three areas of the hand, does not require cords or sensors to be attached to the patient. The device is intended to be used with two of the company’s NeuroStar products, Fast MT and MT Cap.

The D-Tect MT device “aids physicians as they determine the treatment location and treatment level for new patients,” the company said.